Home/Filings/4/0000899243-21-046751
4//SEC Filing

Larson Yi 4

Accession 0000899243-21-046751

CIK 0001831283other

Filed

Dec 2, 7:00 PM ET

Accepted

Dec 3, 4:05 PM ET

Size

5.5 KB

Accession

0000899243-21-046751

Insider Transaction Report

Form 4
Period: 2021-12-01
Larson Yi
Chief Financial Officer
Transactions
  • Award

    Stock Option (Right to Buy)

    2021-12-01+5,9961,202,841 total
    Exercise: $16.00Exp: 2031-12-01Ordinary Shares (5,996 underlying)
Footnotes (1)
  • [F1]25% of the shares underlying the option shall vest and become exercisable on December 1, 2022; the remainder shall vest and become exercisable in three equal annual installments such that the option shall be fully vested on December 1, 2025, subject to the Reporting Person providing continuous service to the Issuer on each such date.

Issuer

LianBio

CIK 0001831283

Entity typeother

Related Parties

1
  • filerCIK 0001785987

Filing Metadata

Form type
4
Filed
Dec 2, 7:00 PM ET
Accepted
Dec 3, 4:05 PM ET
Size
5.5 KB